2016 a year of milestones, accomplishments for VUMC
A roundup of the news that made headlines at Vanderbilt University Medical Center in 2016. View...
Investigational new drug for Alzheimer's scheduled for first study in humans
Vanderbilt University scientists have received notification from the U.S. Food and Drug Administration (FDA) that testing in humans may proceed for an investigational new drug for Alzheimer’s disease after more than 10 years of research by scientists at Vanderbilt University and Vanderbilt University Medical Center. View...
Study to explore lymphedema self care for cancer survivors
Vanderbilt University School of Nursing (VUSN) Assistant Professor Jie Deng, Ph.D., R.N., has been awarded a $789,000 research scholar grant by the American Cancer Society to develop and test a self-care program for head and neck cancer survivors diagnosed with secondary lymphedema and fibrosis (LEF). View...
A Helping Hand: Navigators guide patients through complex medical journey
Imagine trying to navigate an unfamiliar Medical Center with appointments sprinkled across numerous buildings, often on different days of the week. Now add a cancer diagnosis, and the emotions that come with that, and traversing unfamiliar surroundings becomes infinitely more difficult. View...
Medical Center honored in multiple national rankings during the year
Vanderbilt University Medical Center (VUMC) placed highly in several national rankings during the past year, including the various rankings conducted by U.S. News and World Report. View...
Appointments in 2016 strengthen VUMC's core missions
New people and new responsibilities added to the vibrancy of VUMC in 2016. View...
New Year's parking and shuttle schedule announced
Staff working on Jan. 2 should continue to park in assigned areas, with the exception of N Lot and Lot 127 parkers. View...
VUMC in the news
A roundup of a few recent positive stories from the press about Vanderbilt University Medical Center. View...